Videos
Keynote & Fireside Chat
Join us as we kick-off Day 1 of our Moonshots for Health conference with a fireside chat with Sami Inkinen of Virta Health and journalist & author Gary Taubes
Rethinking Obesity Strategy: Combatting the GLP-1 Tsunami
Whether your organization has felt the tidal wave of GLP-1 claims yet or not—it’s coming. With an annual price tag of $12,000+ per patient per year, possibly for the rest of the patient’s life, the cost to employers and health plans will be staggering. Employers and health plans have a new set of options to navigate this spike, but the time to reconsider obesity strategies is now.
Debating the Ethics of GLP-1s
GLP-1s remain a controversial topic—while they have been shown to help patients rapidly lose weight, concerns remain about utilization management, cost-effectiveness, the emergence of “digital pill mills”, and aggressive pharmaceutical marketing practices. In this session we’ll bring together two experts to debate the ethics of GLP-1s, and their implications for the future.
New Trends Reshaping Health Equity
Health equity has stayed at the top of headlines for the past year, but the rise of GLP-1s and the evolving policy landscape present new challenges to affordability and access. In this session, we’ll ask executives to share new trends they've seen in health equity, and how they plan to address them amidst the changes in election year.
Debating the Ethics of GLP-1s
Diabetes and obesity are two of the biggest and most costly chronic diseases in the country. “Diabesity” is an epidemic, and it disproportionately impacts people of color and those with lower socioeconomic status. And while the pursuit of health equity is a popular topic of conversation, the hard work to actually reduce inequities requires bold risk-taking and constant iteration in how we deliver care. In this session, industry leaders will share details in their effort in making equitable care a reality in their organizations.
.svg)